BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25552727)

  • 21. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
    Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM
    Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live attenuated influenza vaccine (Fluenz™): a guide to its use in the prevention of seasonal influenza in children in the EU.
    Scott LJ; Carter NJ; Curran MP
    Paediatr Drugs; 2012 Aug; 14(4):271-9. PubMed ID: 22702743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutinin.
    Lee YJ; Jang YH; Kim P; Lee YH; Lee YJ; Byun YH; Lee KH; Kim K; Seong BL
    Virology; 2016 Apr; 491():1-9. PubMed ID: 26874012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model.
    Kim M; Cheong Y; Lee J; Lim J; Byun S; Jang YH; Seong BL
    Front Immunol; 2021; 12():779223. PubMed ID: 34925355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
    Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    Ghorbani A; Abundo MC; Ji H; Taylor KJM; Ngunjiri JM; Lee CW
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
    Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
    Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
    Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC
    Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live attenuated influenza vaccine tetravalent: a clinical review.
    Bandell AR; Simões EA
    Expert Rev Vaccines; 2015 Jul; 14(7):963-73. PubMed ID: 25864428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink.
    Caspard H; Steffey A; Mallory RM; Ambrose CS
    BMJ Open; 2018 Dec; 8(12):e023118. PubMed ID: 30530581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.
    Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD
    Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
    King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
    J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Shen Z; Bowen RA; Ge P; Yu J; Shen Y; Kong W; Jiang C; Wu J; Zhu C; Xu Y; Wei W; Rudenko L; Kiseleva I; Xu F
    Vaccine; 2016 Nov; 34(48):5953-5958. PubMed ID: 27997342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal influenzavirus vaccine in children.
    Edwards KM; Dupont WD
    N Engl J Med; 1998 Sep; 339(13):922; author reply 922-3. PubMed ID: 9750091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.